Skip to main navigation
Skip to main content
KASL
Contact us
mobile search button
mobile menu button
Search
Advanced Search
ABOUT
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
Page Path
HOME
Search
Peng Wei
WHERE t1.sid in(parameter_dbtbl_author like '%Peng Wei%') and t1.xml_status <> 99
1
results for
"Peng Wei"
Filter
Article category
Correspondence (1)
Keywords
Biomarkers (1)
Hepatocellular carcinoma (1)
Immunotherapy (1)
Liver cancer (1)
Publication year
2025 (1)
Keywords
Biomarkers (1)
Hepatocellular carcinoma (1)
Immunotherapy (1)
Liver cancer (1)
Cancel
Close
Publication Year
2025 (1)
Cancel
Close
Funded articles
Cancel
Close
"Peng Wei"
Correspondence
Hepatic neoplasm
Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Peng Wei, Ju-Seog Lee
Clin Mol Hepatol
2025;31(1):e110-e112.
Published online October 2, 2024
DOI:
https://doi.org/10.3350/cmh.2024.0828
PDF
4,974
View
58
Download
First
Prev
Page
of 1
Next
Last
×
TOP
First
Prev
